Nociceptin, Phe1ψ‐nociceptin1–13, nocistatin and prepronociceptin154–181 effects on calcium channel currents and a potassium current in rat locus coeruleus in vitro
- 1 December 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 128 (8) , 1779-1787
- https://doi.org/10.1038/sj.bjp.0702971
Abstract
1. The actions of the neuropeptide nociceptin, the putative nociceptin receptor antagonist [Phe1psi(CH(2)-NH)Gly(2)]-nociceptin-(1 - 13)NH(2) (Phe(1)psi-nociceptin(1 - 13)) and the putative nociceptin precursor products nocistatin (rat prepronociceptin(125 - 132)) and rat prepronociceptin(154 - 181) were examined on membrane properties of rat locus coeruleus (LC) neurons using whole cell patch clamp techniques. 2. Nociceptin inhibited I(Ba) in all LC neurons, (pD(2) of 8.9, maximum inhibition 50%). The inhibition of I(Ba) by nociceptin was associated with slowing of the activation of I(Ba) and could be significantly reversed by a strong depolarizing prepulse. Phe(1)psi-nociceptin(1 - 13) also inhibited I(Ba) in LC neurons (notional pD(2) of 7.6, maximum inhibition 18%). Application of Phe(1)psi-nociceptin(1 - 13) (1 microM) significantly occluded the subsequent effects of a co-application of nociceptin (3 nM) on I(Ba). 3. As previously reported for nociceptin, Phe(1)psi-nociceptin(1 - 13) caused an outward current in LC neurons voltage clamped at -60 mV (pD(2) of 7.1, maximum current 50% of that of methionine enkephalin, 10 microM). The Phe(1)psi-nociceptin(1 - 13) induced current reversed polarity at -112 mV and exhibited pronounced inward rectification. Phe(1)psi-nociceptin(1 - 13) (1 microM) reversibly inhibited the current caused by nociceptin (300 nM) by 30%. 4. Neither nocistatin nor rat prepronociceptin(154 - 181) inhibited I(Ba) in LC neurons, or prevented the subsequent inhibition by nociceptin. Neither nocistatin or prepronociceptin(154 - 181) affected the membrane properties of LC neurons. 5. This study demonstrates that nociceptin modulates somatic I(Ba) in rat LC neurons. The putative ORL1 antagonist Phe(1)psi-nociceptin(1 - 13) exhibited partial agonist activity at inhibiting I(Ba) and opening K(+) channels in LC. Other putative nociceptin precursor products were without effect on LC cells.Keywords
This publication has 50 references indexed in Scilit:
- ORL1, a novel member of the opioid receptor familyPublished by Wiley ,2001
- Nociceptin inhibits non‐adrenergic non‐cholinergic contraction in guinea‐pig airwayBritish Journal of Pharmacology, 1998
- Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assayBritish Journal of Pharmacology, 1998
- Anti-nociceptive responses produced by human putative counterpart of nocistatinBritish Journal of Pharmacology, 1998
- [Phe1Ψ(CH2-NH)Gly2]-nociceptin-(1-13)NH2, a proposed antagonist of the nociceptin receptor, is a potent and stable agonist in the rat spinal cordNeuroscience Letters, 1998
- Biochemical Evidence for Orphanin FQ/Nociceptin Receptor Heterogeneity in Mouse BrainBiochemical and Biophysical Research Communications, 1997
- Orphanin FQ: A Neuropeptide That Activates an Opioidlike G Protein-Coupled ReceptorScience, 1995
- Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptorNature, 1995
- cDNA Cloning of an orphan opiate receptor gene family member and its splice variantFEBS Letters, 1994
- The locus coeruleus: A cytoarchitectonic, golgi and immunohistochemical study in the albino ratBrain Research, 1976